Free Trial

Northland Capmk Has Bearish Forecast for DocGo Q3 Earnings

DocGo logo with Medical background

Key Points

  • Northland Capmk has lowered its Q3 2025 earnings per share estimate for DocGo to ($0.09), down from ($0.06), indicating a pessimistic outlook for the company.
  • DocGo's previous quarterly earnings report showed a loss of ($0.11) per share, which missed the consensus estimate by ($0.05), alongside a negative net margin of 4.20%.
  • Analyst ratings for DocGo are mixed, with a current consensus of “Moderate Buy”, and price targets ranging from $1.45 to $3.00 following adjustments from various firms.
  • Five stocks to consider instead of DocGo.

DocGo Inc. (NASDAQ:DCGO - Free Report) - Analysts at Northland Capmk decreased their Q3 2025 earnings per share estimates for shares of DocGo in a research report issued on Monday, August 11th. Northland Capmk analyst M. Latimore now anticipates that the company will post earnings per share of ($0.09) for the quarter, down from their previous forecast of ($0.06). The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q4 2025 earnings at ($0.09) EPS, FY2025 earnings at ($0.36) EPS and Q1 2026 earnings at ($0.02) EPS.

A number of other research analysts also recently weighed in on the company. BTIG Research downgraded DocGo from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Canaccord Genuity Group restated a "hold" rating and set a $1.45 price objective (down from $5.00) on shares of DocGo in a research note on Monday, May 12th. Finally, Needham & Company LLC cut their price objective on shares of DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, DocGo currently has an average rating of "Moderate Buy" and a consensus price target of $3.56.

Read Our Latest Stock Report on DCGO

DocGo Stock Down 0.6%

NASDAQ:DCGO traded down $0.01 during trading hours on Wednesday, hitting $1.62. 956,426 shares of the stock were exchanged, compared to its average volume of 526,617. The company's 50 day moving average is $1.52 and its two-hundred day moving average is $2.39. DocGo has a twelve month low of $1.23 and a twelve month high of $5.68. The company has a market capitalization of $158.45 million, a P/E ratio of -8.53 and a beta of 0.96.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. The company had revenue of $80.42 million for the quarter, compared to the consensus estimate of $77.58 million.

Hedge Funds Weigh In On DocGo

Several hedge funds and other institutional investors have recently bought and sold shares of DCGO. Summit Securities Group LLC acquired a new stake in shares of DocGo in the 1st quarter worth about $34,000. CWM LLC increased its stake in shares of DocGo by 2,613.3% during the 2nd quarter. CWM LLC now owns 21,978 shares of the company's stock worth $35,000 after purchasing an additional 21,168 shares during the last quarter. Cerity Partners LLC purchased a new stake in shares of DocGo during the 2nd quarter worth approximately $37,000. Summit Investment Advisors Inc. increased its stake in shares of DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares during the last quarter. Finally, Engineers Gate Manager LP purchased a new stake in shares of DocGo during the 2nd quarter worth approximately $52,000. Institutional investors and hedge funds own 56.44% of the company's stock.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Recommended Stories

Earnings History and Estimates for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.